RTT

Merck Manuals Survey Finds Majority of Americans Rarely Think About Hearing Loss

Retrieved on: 
Thursday, August 16, 2018
Perception, Occupational safety and health, Audiology, Hearing, Health, Industrial hygiene, Hearing loss, Otorhinolaryngology, RTT, Hearing aid, Hearing conservation program

Yet many people admit they don't often think about hearing loss and are reluctant to use some of the most effective hearing loss prevention and treatment techniques.

Key Points: 
  • Yet many people admit they don't often think about hearing loss and are reluctant to use some of the most effective hearing loss prevention and treatment techniques.
  • A survey released today from the Merck Manuals found that 59 percent of Americans say they rarely think about hearing loss.
  • Dr. Lustig, who authored the chapters on hearing loss for the Merck Manuals, emphasized that hearing aids are often an effective way to regain some hearing loss.
  • According to the Merck Manuals survey, 63 percent of Americans said getting hearing aids is essential to quality of life for those with hearing loss.

The National Football League Alumni, Cancer Treatment Centers of America®, LabCorp® and Health Testing Centers Team Up to Offer Prostate Cancer Screenings in September

Retrieved on: 
Thursday, August 16, 2018
Medicine, Prostate cancer, Cancer, Clinical medicine, RTT, Men's Health, Cancer screening, Prostate cancer screening, Cancer Treatment Centers of America, Prostate, Prostate Cancer Foundation of Australia, Active surveillance of prostate cancer

Beginning in September (Prostate Cancer Awareness Month), the Prostate Pep Talk messaging will encourage men to get screened for prostate cancer.

Key Points: 
  • Beginning in September (Prostate Cancer Awareness Month), the Prostate Pep Talk messaging will encourage men to get screened for prostate cancer.
  • Eligible men may order their free or discounted PSA screening by visiting Prostate Pep Talk or Health Testing Centers - Prostate Pep Talk .
  • Health Testing Centers is a mission-driven company on the forefront of movement toward transparency and greater control in health care through personalized preventive care.
  • Cancer Treatment Centers of America Global, Inc. (CTCA) is a comprehensive cancer care network of hospitals and outpatient care centers in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa.

Dronedarone Promotes Cardiac Repair After a Heart Attack

Retrieved on: 
Thursday, August 16, 2018
Medicine, Aging-associated diseases, Medical emergencies, Antiarrhythmic agents, Chemistry, RTT, Benzofurans, Dronedarone, Myocardial infarction, Organic chemistry

WASHINGTON, Aug. 16, 2018 /PRNewswire/ --An article published in Experimental Biology and Medicine (Volume 243, Issue 11, July, 2018) ( http://journals.sagepub.com/doi/pdf/10.1177/1535370218788517 ) reports that the antiarrhythmic drug, dronedarone, promotes cardiac repair after a heart attack.

Key Points: 
  • WASHINGTON, Aug. 16, 2018 /PRNewswire/ --An article published in Experimental Biology and Medicine (Volume 243, Issue 11, July, 2018) ( http://journals.sagepub.com/doi/pdf/10.1177/1535370218788517 ) reports that the antiarrhythmic drug, dronedarone, promotes cardiac repair after a heart attack.
  • Acute myocardial infarction, or heart attack, is the leading cause of death in the western world.
  • Disability may develop in surviving patients due to the remaining dysfunction of the myocardial microcirculation or heart injury.
  • Dr. Lendeckel added: "To what extent dronedarone can improve cardiac functionality in the long term, remains to be assessed in future studies.

WellBrain, Founded by 3 Harvard, Stanford, and Mayo Clinic Trained Physicians, Expands Its Reach as One of the Largest Clinically-Validated, Digital Chronic Pain Management and Addiction Prevention Tools With Recent Mevoked Acquisition

Retrieved on: 
Thursday, August 16, 2018
Pain, Perception, RTT, Nociception, Acute pain, Pain management, Psychiatric diagnosis, Childbirth, Major depressive disorder, Chronic pain, Addiction

Mevoked has developed an online and mobile data analytics tool that correlates technology use with behavior.

Key Points: 
  • Mevoked has developed an online and mobile data analytics tool that correlates technology use with behavior.
  • Mevoked's first product leverages this analytics to help support women and prevent, treat, and manage, perinatal/postpartum depression and anxiety.
  • By joining forces, WellBrain, founded by 3 Harvard, Stanford, and Mayo Clinic trained physicians, expand its reach as one of the largest clinically-validated, digital chronic pain management and addiction prevention tools and now helps more than 30,000 patients monthly across 18 states.
  • and CEO, Sumeet Maniar see the move as helping build "the most powerful, AI/ML and data-driven addiction prevention and chronic pain management tool on the market."

Investigation Report on Chinese Ossotide Market, 2018-2022 - Annual Sales Value of Ossotide in China Increased From Less than CNY 120 Million in 2007 to CNY 363 Million in 2017

Retrieved on: 
Wednesday, August 15, 2018
RTT, Medicine, Arthritis, Skeletal disorders, Immunology, Anatomy, Rheumatology, Connective tissue diseases, Osteoarthritis, Rheumatoid arthritis

Like rheumatoid arthritis, osteoarthritis is one of the most common arthritis and a manifestation of articular degeneration with age.

Key Points: 
  • Like rheumatoid arthritis, osteoarthritis is one of the most common arthritis and a manifestation of articular degeneration with age.
  • At the end of 2017, the number of people aged 60 and above reached 241 million in China, accounting for 17.3% of the total population.
  • According to the researcher, after Ossotide was launched in China, the sales value of Ossotide kept growing before 2012 and fluctuated from 2013 to 2017.
  • Overall, the annual sales value in China increased from less than CNY 120 million in 2007 to CNY 363 million in 2017.

China Insulin Glargine Market, 2018-2022 - Sales Value of Insulin Glargine has Been Growing Since it Entered China and Exceeded CNY 800 Million in 2017

Retrieved on: 
Wednesday, August 15, 2018
Endocrine system, Medicine, Peptide hormones, Recombinant proteins, Clinical medicine, RTT, Eli Lilly and Company, Diabetes, Insulin, Zhuhai, Diabetes mellitus, Insulin glargine/lixisenatide

According to WHO's data, there are about 110 million diabetics in China, about 1/10 of China's adults.

Key Points: 
  • According to WHO's data, there are about 110 million diabetics in China, about 1/10 of China's adults.
  • Insulin Glargine is the first long-acting insulin produced by simulating recombinant DNA technology.
  • The sales value has been growing since Insulin Glargine entered China and exceeded CNY 800 million in 2017.
  • 2 Sales of Insulin Glargine in China, 2013-2017
    2.3 Sales of Insulin Glargine by Dosage Form in China, 2013-2017
    3 Analysis onMajor Insulin Glargine Manufacturers in China, 2013-2017
    3.4 Zhuhai United Laboratories Co., Ltd.
    3.4.2 Sales of Zhuhai United Laboratories Co., Ltd.'s Insulin Glargine in China
    4 Prices of Different Manufacturers' Insulin Glargine in China, 2017-2018
    4.4 Zhuhai United Laboratories Co., Ltd. (USLEN)
    5 Prospect of Chinese Insulin Glargine Market, 2018-2022

Help Your Diabetes National Clinic Rollout Is In Full Swing With Plans For 30 Clinics By End Of 2018 And 60 By Mid 2019

Retrieved on: 
Wednesday, August 15, 2018
Diabetes mellitus, RTT

The Founder/CEO, Dr. J. Murray Hockings, has 27 years of experience in healthcare and is the author of "Imagine Living Without Type 2 Diabetes.

Key Points: 
  • The Founder/CEO, Dr. J. Murray Hockings, has 27 years of experience in healthcare and is the author of "Imagine Living Without Type 2 Diabetes.
  • Dr. Hockings has given over 240 diabetes seminars in 5 countries the past 6 years and is known as "The World's #1 Diabetes Doctor."
  • HYD Lancaster will open on August 20, 2018 and HYD Salt Lake City will be open by September 10, 2018.
  • By the end of 2018 HYD expects to have 12 clinics open and another 18 under construction, with 60 projected by mid 2019.

Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA's new resource guide to support responsible opioid prescribing for pain management in animals

Retrieved on: 
Wednesday, August 15, 2018
Pain, Perception, Medicine, RTT, Opioids, Nociception, Acute pain, Pain management, Analgesic, Heroin, Chronic pain, Addiction

One such important care group is veterinarians who may prescribe them to manage pain in animals.

Key Points: 
  • One such important care group is veterinarians who may prescribe them to manage pain in animals.
  • Our training " blueprint " provides information on acute and chronic pain management; safe use of opioid analgesics or other non-opioid or non-drug treatments; as well as material on addiction medicine and opioid use disorders.
  • That's why we have developed a new resource containing information and recommendations specifically for veterinarians who stock and administer opioids.
  • We recognize that opioids and other pain medications have a legitimate and important role in treating pain in animals just as they do for people.

Branded Direct-to-Consumer Advertising Likely to Provide a Bump in Patient Requests for Sanofi/Regeneron's Dupixent, but Insurance Coverage and Out-of-Pocket Costs Continue to be Key Barriers for the Only Approved Atopic Dermatitis Biologic

Retrieved on: 
Wednesday, August 15, 2018
Immunology, Type I hypersensitivity, RTT, Medicine, Monoclonal antibodies, Atopic dermatitis, Janus kinase inhibitor, Dupilumab, Atopy, Dermatitis

Lack of insurance coverage continues to be the most commonly cited barrier to use, while out-of-pocket costs have become a growing concern amongst dermatologists.

Key Points: 
  • Lack of insurance coverage continues to be the most commonly cited barrier to use, while out-of-pocket costs have become a growing concern amongst dermatologists.
  • Of note, however, when patient requests did occur prior to branded advertising, one-quarter attempted to prescribe Dupixent, but could not due to insurance issues.
  • In regard to the busy pipeline, dermatologists believe JAK inhibitors and IL-13 inhibitors have the greatest potential for treating moderate-to-severe atopic dermatitis.
  • RealWorld Dynamix: Moderate-to-Severe Atopic Dermatitis (US) is a large-scale patient audit of recently seen moderate-to-severe atopic dermatitis patients.

Village Naturals Therapy Commits to Helping Chronic Pain Sufferers

Retrieved on: 
Wednesday, August 15, 2018
Pain, Perception, Nociception, Pain management, RTT, Rheumatology, Acute pain, Fibromyalgia, Chronic pain

NFA's Proud Sponsor Program acknowledges companies' products that are safe, effective and beneficial to the fibromyalgia and chronic pain community.

Key Points: 
  • NFA's Proud Sponsor Program acknowledges companies' products that are safe, effective and beneficial to the fibromyalgia and chronic pain community.
  • In addition to their work with NFA and CPC, Village Naturals Therapy understands chronic pain sufferers need an outlet to share their concerns and hear success stories from others.
  • This month, Village Naturals Therapy will be launching Village Warriors , a Facebook community page for sharing concerns and tips for managing chronic pain.
  • For chronic pain sufferers, Village Naturals Therapys' most popular lines include Aches + Pains Muscle Relief and Nighttime Relief.